Abstract
Sickle cell anemia (SCA) features complex pathophysiology and is characterized by the polymerization of hemoglobin (Hb) S and consequent hemolysis, vascular occlusion, oxidative stress and increased medullary request. These pathophysiologic processes difficult the treatment and culminate in the development of diverse clinical manifestations that are modulated by genetic and biochemical ma…